Roivant Sciences Ltd. number of employees

Roivant Sciences Ltd. reported 721 employees at March 31, 2026 in its latest annual report, down 29 (3.9%) on the year before. That compares with 863 at March 31, 2022. Revenue per employee was $11,456.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
March 31, 2026	721	−29 (3.9%)	$11,456	10-K, filed May 20, 2026
March 31, 2025	750	−154 (17.0%)	$38,737	10-K, filed May 29, 2025
March 31, 2023	904	+41 (4.8%)	$34,878	10-K, filed June 28, 2023
March 31, 2022	863	—	$64,063	10-K, filed June 28, 2022

What the annual reports say

Human Capital Management As of March 31, 2026, we and our subsidiaries had approximately 721 full-time employees, including 659 in the U.S. 2026 annual report
Human Capital Management As of March 31, 2025, we and our subsidiaries had approximately 750 full-time employees, including 693 in the U.S. 2025 annual report
Human Capital Management As of March 31, 2023, we and our subsidiaries had approximately 904 full-time employees, including 825 in the United States. 2023 annual report
Human Capital Management As of March 31, 2022, we and our subsidiaries had approximately 863 full-time employees, including 791 in the United States. 2022 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ROIV vs TCRX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Roivant Sciences Ltd.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Roivant Sciences Ltd.